Institutional
IDIBAPS and CAPSBE sign new cooperation agreement
The aim of the agreement is to promote the development of joint research activities.
News about IDIBAPS
Institutional
The IDIBAPS sustainability manual is now available
The manual is a living document addressed to IDIBAPS’ employees, collaborators and visitors aimed at contributing to the sustainability of the inst...
Research
Deep brain stimulation improves symptoms in patients with treatment-resistant schizophrenia and bipolar disorder
Led by researchers from IDIBAPS-Hospital Clínic Barcelona, the study shows that the technique can be a safe and effective alternative for complex c...
Institutional
Health Circuit wins second prize at the 2023 HITLAB Breakthrough Alliance Challenge
The spin-off of FCRB-IDIBAPS was awarded the prize for SurgifitTM, a digital preoperative preparation platform that makes it possible to reduce the...
Research
Josep M. Llovet appointed editor-in-chief of the Journal of Hepatology Reports
The candidature of the Clínic-IDIBAPS researcher was approved with 90% of the votes at the general assembly of the European Association for the Stu...
Research
IDIBAPS creates three multidisciplinary research programs to encourage collaboration among its groups
They are the Translational cancer research program, the Synaptic autoimmunity in neurology, psychiatry and cognitive neuroscience program and the L...
Research
The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance
The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personal...
Research
Researchers at IDIBAPS Hospital-Clínic Barcelona receive two grants from the Mutua Madrileña Foundation
One of the projects is coordinated by Glòria Garrabou, the head of the group Hereditary metabolic diseases and muscular diseases, and the other by...
Research
First genetic marker for Multiple Sclerosis severity identified
This finding, published today in the journal Nature, opens the door to the development of new treatments to prevent long-term disability.